Mosquitoes like this one spread malaria
Malaria was once under control. But was before the malaria parasite became resistant, in many parts of the world, to the drug that had long been used to treat it, chloroquine.
The National Institutes of Health has awarded a grant of nearly $3 Million to a Portland biotech startup, DesignMedix, Inc. President Sandra Shotwell, Ph.D, says they’ve modified the once-successful malaria drug to block that resistance, so the drug works again.
Shotwell says the federal grant is “fantastic” and gives DesignMedix, which has ties to Portland State University, the resources to eventually test the drug on humans.
Shotwell says more than half-a-million children die each year from malaria.
Photo Courtesy: Associated Press